13 November, 2021

More Reasons to Halt the Vaccination Mandates

Britain Becomes First Country To Approve Merck COVID-19 Pill | The Daily Wire

“The pill was licensed for adults 18 and older who have tested positive for COVID-19 and have at least one risk factor for developing severe disease, such as obesity or heart disease. Patients with mild-to-moderate COVID-19 would take four pills of the drug, known molnupiravir, twice a day for five days,” The Associated Press reported.

The country is the first in the world to approve use of the drug, which could potentially lead to other nations doing the same.

We can treat this now. We should treat it now.

Waiting on the FDA here in the U.S.A.

“Merck has submitted an Emergency Use Authorization (EUA) application to the U.S. Food and Drug Administration (FDA) for molnupiravir, an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and/or hospitalization,” Merck announced in a press release. “The companies are actively working with regulatory agencies worldwide to submit applications for emergency use or marketing authorization in the coming months.”

No comments:

Post a Comment